← Leaderboards
Steven K. Libutti
Rutgers Biomedical And Health Sciences
$7,794,095
Attributed
$14,798,844
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.8M · FY2012–25$10M$7.5M$5M$2.5M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$52,394,653 · 11
By mechanism
P30$41,238,330 · 5
R01$6,250,365 · 3
U01$4,443,596 · 1
U54$330,151 · 1
T32$132,211 · 1
Top collaborators
- Renata Pasqualini10 shared
- Richard N Kitsis8 shared
- Wadih Arap5 shared
- Sha X Chang5 shared
- Reynold Alexander Panettieri5 shared
- William C Zamboni5 shared
- Joachim B. Kohn1 shared
- Pragati Sharma1 shared
Most similar at Rutgers Biomedical And Health Sciences
Same institution · by research overlap
- Renata Pasqualini$15,543,620
- Wadih Arap$12,814,372
- Elisa V Bandera$5,946,911
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsProgramsCancer Institute Of New JerseyCollaborationsUniversitiesResourcesClinical TrialsVisionInnovationScienceCancer Center Support GrantScreeningClinical ResearchMissionBasic ScienceEvaluationMemberResource SharingTranslatingGrowthMetabolomicsResearch PersonnelCatchment AreaNew Jersey
Grant awards (64)
Cancer Center Support Grant$3,504,376
P30 · FY2025 · CA · contact PI
Minibeam Radiation Therapy Enhanced Delivery of Nanoparticle Anticancer Agents to Pancreatic Cancer Tumors$555,851
R01 · FY2025 · CA
Personalized Modeling of CAR-T Cell Immunotherapy Using iPSC-Derived Effectors and Patient- Derived Tumor Organoids$499,999
P30 · FY2025 · CA · contact PI
Developmental Funds$269,566
P30 · FY2025 · CA · contact PI
Leadership, Planning and Evaluation$269,566
P30 · FY2025 · CA · contact PI
The effects of obesity and GLP-1R/GIPR agonists on early-onset breast cancer risk$114,250
P30 · FY2025 · CA · contact PI
Cancer Center Support Grant$60,000
P30 · FY2025 · CA · contact PI
Cancer Center Support Grant$3,504,376
P30 · FY2024 · CA · contact PI
Minibeam Radiation Therapy Enhanced Delivery of Nanoparticle Anticancer Agents to Pancreatic Cancer Tumors$528,058
R01 · FY2024 · CA
Designing a transcriptome-based, targeted theranostic platform for prostate cancer$341,181
R01 · FY2024 · CA
Developmental Funds$274,813
P30 · FY2024 · CA · contact PI
Cancer Center Support Grant$200,000
P30 · FY2024 · CA · contact PI
Leadership, Planning and Evaluation$198,209
P30 · FY2024 · CA · contact PI
National Cancer Institute Early Career Cancer Clinical Investigator Award$60,000
P30 · FY2024 · CA · contact PI
Cancer Center Support Grant$3,025,267
P30 · FY2023 · CA · contact PI
Cancer Center Support Grant$1,507,000
P30 · FY2023 · CA · contact PI
Minibeam Radiation Therapy Enhanced Delivery of Nanoparticle Anticancer Agents to Pancreatic Cancer Tumors$544,735
R01 · FY2023 · CA
Developmental Funds$368,469
P30 · FY2023 · CA · contact PI
Designing a transcriptome-based, targeted theranostic platform for prostate cancer$351,955
R01 · FY2023 · CA
Scholars and Early-Stage Investigator Advancement Initiative (SEA)$200,000
P30 · FY2023 · CA · contact PI
Leadership, Planning and Evaluation$111,968
P30 · FY2023 · CA · contact PI
Cancer Center Support Grant$3,025,267
P30 · FY2022 · CA · contact PI
Cancer Center Support Grant$1,506,999
P30 · FY2022 · CA · contact PI
Rutgers Optimizes Innovation (ROI) Program$999,999
U01 · FY2022 · HL
Minibeam Radiation Therapy Enhanced Delivery of Nanoparticle Anticancer Agents to Pancreatic Cancer Tumors$544,735
R01 · FY2022 · CA
Designing a transcriptome-based, targeted theranostic platform for prostate cancer$351,955
R01 · FY2022 · CA
Developmental Funds$318,178
P30 · FY2022 · CA · contact PI
Immune Radiation Response Index (i- RRI) for Immune Cells from Normal and Tumor Microenvironments$166,812
P30 · FY2022 · CA · contact PI
Leadership, Planning and Evaluation$61,676
P30 · FY2022 · CA · contact PI
Cancer Center Support Grant$3,025,267
P30 · FY2021 · CA · contact PI
T-Cell Receptor Discovery for Engineered T-cell Therapy for Human Cancers$1,508,494
P30 · FY2021 · CA · contact PI
Rutgers Optimizes Innovation (ROI) Program$999,999
U01 · FY2021 · HL
Minibeam Radiation Therapy Enhanced Delivery of Nanoparticle Anticancer Agents to Pancreatic Cancer Tumors$569,509
R01 · FY2021 · CA
Developmental Funds$476,285
P30 · FY2021 · CA · contact PI
Rutgers Optimizes Innovation (ROI) Program$443,600
U01 · FY2021 · HL
Designing a transcriptome-based, targeted theranostic platform for prostate cancer$358,185
R01 · FY2021 · CA
Development of Standardized Electronic Treatment Plan Builds for NCI-Supported Clinical Trials Applicable Across Clinical Research Sites; In conjunction with the Big Ten EHR Consortium-Year 2$300,000
P30 · FY2021 · CA · contact PI
Leadership, Planning and Evaluation$92,324
P30 · FY2021 · CA · contact PI
Cancer Center Support Grant$3,028,552
P30 · FY2020 · CA · contact PI
Rutgers Optimizes Innovation (ROI) Program$999,999
U01 · FY2020 · HL
Developmental Funds$476,270
P30 · FY2020 · CA · contact PI
Cancer Center Support Grant$390,587
P30 · FY2020 · CA · contact PI
Designing a transcriptome-based, targeted theranostic platform for prostate cancer$356,850
R01 · FY2020 · CA
Development of Standardized Electronic Treatment Plan Builds for NCI-Supported Clinical Trials Applicable Across Clinical Research Sites; In conjunction with the Big Ten EHR Consortium$299,523
P30 · FY2020 · CA · contact PI
Cancer Center Support Grant$199,788
P30 · FY2020 · CA · contact PI
Leadership, Planning and Evaluation$92,309
P30 · FY2020 · CA · contact PI
Cancer Center Support Grant$3,036,738
P30 · FY2019 · CA · contact PI
Rutgers Optimizes Innovation (ROI) Program$999,999
U01 · FY2019 · HL
Developmental Funds$551,431
P30 · FY2019 · CA · contact PI
Leadership, Planning and Evaluation$81,457
P30 · FY2019 · CA · contact PI
Cancer Center Support Grant$2,945,906
P30 · FY2018 · CA · contact PI
Cancer Center Support Grant$2,945,907
P30 · FY2017 · CA · contact PI
Cancer Center Support Grant$125,000
P30 · FY2017 · CA · contact PI
Deciphering the Tissue Specificity of MEN1 Related Tumorigenesis$45,916
R01 · FY2017 · CA · contact PI
Cancer Center Support Grant$2,415,701
P30 · FY2016 · CA · contact PI
Deciphering the Tissue Specificity of MEN1 Related Tumorigenesis$195,190
R01 · FY2016 · CA · contact PI
Deciphering the Tissue Specificity of MEN1 Related Tumorigenesis$151,331
R01 · FY2016 · CA · contact PI
Deciphering the Tissue Specificity of MEN1 Related Tumorigenesis$309,910
R01 · FY2015 · CA · contact PI
Training of Surgeons for Studies of the Tumor Microenvironment$132,211
T32 · FY2015 · CA · contact PI
Deciphering the Tissue Specificity of MEN1 Related Tumorigenesis$36,616
R01 · FY2015 · CA · contact PI
Deciphering the Tissue Specificity of MEN1 Related Tumorigenesis$336,129
R01 · FY2014 · CA · contact PI
Multifunctional Nanoassemblies for Ligand-directed Imaging and Therapy of Endocri$330,151
U54 · FY2014 · CA · contact PI
Deciphering the Tissue Specificity of MEN1 Related Tumorigenesis$325,734
R01 · FY2013 · CA · contact PI
Deciphering the Tissue Specificity of MEN1 Related Tumorigenesis$346,525
R01 · FY2012 · CA · contact PI